IDEAS home Printed from https://ideas.repec.org/h/spr/sprchp/978-3-642-55345-5_16.html
   My bibliography  Save this book chapter

Multi-state Models Used in Oncology Trials

In: Developments in Statistical Evaluation of Clinical Trials

Author

Listed:
  • Birgit Gaschler-Markefski

    (Boehringer Ingelheim Pharma GmbH and Co. KG, Department of Biostatistics)

  • Karin Schiefele

    (University Ulm, Department of Epidemiology and Medical Biometry)

  • Julia Hocke

    (Boehringer Ingelheim Pharma GmbH and Co. KG, Department of Biostatistics)

  • Frank Fleischer

    (Boehringer Ingelheim Pharma GmbH and Co. KG, Department of Biostatistics)

Abstract

Among the surrogate endpoints for overall survival (OS) overall survival in oncological trials, progression-free survival (PFS) is used as an important endpoint especially in first or second line of cancer therapies. Basic formulae for the determination of sample sizes based on time to event data can be found in the literature. Assumptions about the distributions of the survival time for OS and PFS, the accrual time and the censoring time are of key importance. Most often only uniformly distributed patient accrual and no censoring are mentioned, whereas the event time is assumed to be exponentially distributed. Considering the dependence between PFS and OS, we will investigate how a three-state model that includes states of progression/response and death can be used for a joint modelling of progression-free survival and overall survival. Sample size/power calculations are discussed for the three-state model and compared to the estimations based on exponentially distributed OS times. These sample size calculations are based on the assumption of piecewise uniformly accrual and exponentially distributed censoring time. The new three-state model approach results in a 10–30 % lower sample size and a corresponding higher power. An application to a Phase III lung cancer trial illustrates how the new approach can be successfully applied to the planning of a trial and to the monitoring of the needed events for the PFS and OS analyses.

Suggested Citation

  • Birgit Gaschler-Markefski & Karin Schiefele & Julia Hocke & Frank Fleischer, 2014. "Multi-state Models Used in Oncology Trials," Springer Books, in: Kees van Montfort & Johan Oud & Wendimagegn Ghidey (ed.), Developments in Statistical Evaluation of Clinical Trials, edition 127, chapter 0, pages 283-304, Springer.
    • Handle: RePEc:spr:sprchp:978-3-642-55345-5_16
    DOI: 10.1007/978-3-642-55345-5_16
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a
    for a similarly titled item that would be available.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:sprchp:978-3-642-55345-5_16. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.